Paramount Cosmetics (India) Ltd
₹ 35.6
-3.83%
28 Aug
- close price
About
Incorporated in 1985, Paramount Cosmetics (India) Limited is in the business of selling and distribution of cosmetic[1]
Key Points
- Market Cap ₹ 17.3 Cr.
- Current Price ₹ 35.6
- High / Low ₹ 48.8 / 30.7
- Stock P/E 75.2
- Book Value ₹ 42.2
- Dividend Yield 0.00 %
- ROCE 7.94 %
- ROE 0.24 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.84 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 4.10% over past five years.
- Company has a low return on equity of -1.38% over last 3 years.
- Earnings include an other income of Rs.1.36 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.36 | 49.08 | 34.85 | 20.98 | 21.86 | 24.18 | 17.50 | 20.18 | 26.72 | 21.81 | 20.38 | 21.39 | 20.07 | |
| 43.44 | 42.34 | 29.53 | 16.50 | 17.47 | 20.27 | 14.91 | 21.10 | 24.07 | 21.39 | 19.39 | 19.87 | 19.34 | |
| Operating Profit | 4.92 | 6.74 | 5.32 | 4.48 | 4.39 | 3.91 | 2.59 | -0.92 | 2.65 | 0.42 | 0.99 | 1.52 | 0.73 |
| OPM % | 10.17% | 13.73% | 15.27% | 21.35% | 20.08% | 16.17% | 14.80% | -4.56% | 9.92% | 1.93% | 4.86% | 7.11% | 3.64% |
| 0.17 | 0.26 | 0.07 | 0.36 | 0.05 | 0.04 | 1.17 | 4.56 | 0.20 | 2.09 | 1.23 | 1.11 | 1.36 | |
| Interest | 1.92 | 3.03 | 3.23 | 2.82 | 2.50 | 2.25 | 2.31 | 2.35 | 1.70 | 1.74 | 1.60 | 1.83 | 1.26 |
| Depreciation | 0.80 | 2.53 | 2.14 | 1.72 | 1.43 | 1.25 | 1.06 | 0.95 | 0.81 | 0.67 | 0.55 | 0.46 | 0.45 |
| Profit before tax | 2.37 | 1.44 | 0.02 | 0.30 | 0.51 | 0.45 | 0.39 | 0.34 | 0.34 | 0.10 | 0.07 | 0.34 | 0.38 |
| Tax % | 27.00% | 45.14% | 600.00% | 90.00% | 125.49% | 128.89% | 10.26% | 41.18% | 38.24% | 80.00% | 57.14% | 82.35% | |
| 1.74 | 0.80 | -0.09 | 0.04 | -0.13 | -0.12 | 0.34 | 0.20 | 0.21 | 0.02 | 0.03 | 0.05 | 0.23 | |
| EPS in Rs | 3.58 | 1.65 | -0.19 | 0.08 | -0.27 | -0.25 | 0.70 | 0.41 | 0.43 | 0.04 | 0.06 | 0.10 | 0.48 |
| Dividend Payout % | 16.76% | 30.38% | -270.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | 4% |
| 3 Years: | -7% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -24% |
| 5 Years: | -32% |
| 3 Years: | -38% |
| TTM: | 560% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 5% |
| 3 Years: | -5% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -5% |
| 3 Years: | -1% |
| Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 | 4.86 |
| Reserves | 18.66 | 19.17 | 16.89 | 16.65 | 14.63 | 14.51 | 14.65 | 14.92 | 15.37 | 15.46 | 15.51 | 15.63 |
| 23.28 | 24.11 | 20.84 | 20.61 | 20.83 | 18.18 | 17.24 | 14.57 | 12.52 | 12.21 | 11.40 | 2.39 | |
| 17.54 | 16.93 | 8.77 | 5.42 | 7.88 | 11.67 | 11.64 | 13.02 | 10.24 | 8.36 | 8.71 | 12.30 | |
| Total Liabilities | 64.34 | 65.07 | 51.36 | 47.54 | 48.20 | 49.22 | 48.39 | 47.37 | 42.99 | 40.89 | 40.48 | 35.18 |
| 25.34 | 23.92 | 22.27 | 20.60 | 19.40 | 18.23 | 17.31 | 16.43 | 15.73 | 14.78 | 14.24 | 13.84 | |
| CWIP | 0.00 | 0.12 | 0.34 | 0.23 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 39.00 | 41.03 | 28.75 | 26.71 | 28.73 | 30.99 | 31.08 | 30.94 | 27.26 | 26.11 | 26.24 | 21.34 | |
| Total Assets | 64.34 | 65.07 | 51.36 | 47.54 | 48.20 | 49.22 | 48.39 | 47.37 | 42.99 | 40.89 | 40.48 | 35.18 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.18 | 0.39 | 6.44 | 3.79 | 4.41 | 4.25 | 2.27 | 0.82 | 3.65 | -0.24 | 1.40 | 10.77 | |
| -8.21 | 1.50 | -0.67 | 0.05 | -0.21 | 0.01 | 0.01 | 4.34 | 0.05 | 2.22 | 0.96 | 0.23 | |
| 1.21 | -3.51 | -5.78 | -3.61 | -4.45 | -4.16 | -2.22 | -5.02 | -4.04 | -2.06 | -2.41 | -10.83 | |
| Net Cash Flow | 0.18 | -1.62 | -0.01 | 0.23 | -0.25 | 0.11 | 0.05 | 0.14 | -0.34 | -0.07 | -0.05 | 0.16 |
| Free Cash Flow | -1.20 | 1.62 | 5.73 | 3.74 | 4.18 | 4.24 | 2.13 | 5.15 | 3.54 | 1.05 | 1.40 | 10.73 |
| CFO/OP | 146% | 6% | 134% | 95% | 103% | 109% | 88% | -95% | 140% | -57% | 141% | 757% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 85.29 | 77.27 | 29.74 | 2.44 | 53.26 | 100.38 | 126.19 | 134.21 | 85.10 | 64.77 | 38.86 | 0.34 |
| Inventory Days | 197.13 | 254.59 | 364.78 | 1,472.85 | 1,345.79 | 1,030.13 | 1,959.47 | 874.23 | 395.64 | 399.38 | 594.07 | 447.94 |
| Days Payable | 140.01 | 147.13 | 109.26 | 136.23 | 266.23 | 171.69 | 411.83 | 227.83 | 78.11 | 48.75 | 50.90 | 31.31 |
| Cash Conversion Cycle | 142.41 | 184.73 | 285.27 | 1,339.06 | 1,132.83 | 958.82 | 1,673.83 | 780.61 | 402.64 | 415.40 | 582.03 | 416.97 |
| Working Capital Days | 59.25 | 76.53 | 55.82 | 94.29 | 13.36 | 6.19 | 50.47 | 86.46 | 74.72 | 148.11 | 152.41 | 155.45 |
| ROCE % | 9.89% | 9.44% | 7.16% | 7.37% | 7.30% | 6.93% | 7.27% | -4.84% | 6.08% | 2.51% | 5.19% | 7.94% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees on Rolls employees |
|
||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Annual General Meeting_30.09.2026
- 41st AGM on September 30, 2026 at 11:00 A.M. via VC/OAVM.
-
CUT OFF DATE/RECORD DATE
- 41st AGM on September 30, 2026; books closed September 24-30, record date September 23.
- The Register Of Members And Share Transfer Books Of The Company Will Remain Closed From Thursday 24.09.2026 To Wednesday 30.09.2026 (Both Days Inclusive) For The Purpose Of AGM.
-
Announcement under Regulation 30 (LODR)-Credit Rating
- CARE withdrew Paramount Cosmetics' bank facility ratings on 17 Aug 2026 after full repayment.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Pursuant to Regulation 33 and 47 of SEBI (LODR) 2015, The Unaudited Financial Statement of the Company for quarter ended 30.06.2026 has been published in …
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1][2]
PCIL, the flagship company of the Paramount group, is
engaged in the manufacturing of beauty and personal care products like bindi, kumkum, kajal, deodorants, etc. The co. is known for its flagship brand,
Shilpa bindis, along with various other brands, including Sunspot (sticker bindis and liquid kumkum),
Kromme (instant eye shadow applicator)
and Instinct (men’s deodorants), etc. Currently, PCIL is into trading, selling & distribution of cosmetics like Bindi, Kumkum, Kajal, and other products
through selling & distribution agreements.